Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly Targeted Drug Delivery Systems

Molecular Pharmaceutics

Volumn 13, Issue 1, 2016, Pages 1-7

  Maity, Amit Ranjan ^a   Stepensky, David ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

barriers for subcellular targeting; decoration with targeting residues; drug delivery systems; exaggerated claims; limited targeting efficiency; subcellular drug targeting

Indexed keywords

CELL PENETRATING PEPTIDE; DENDRIMER; LIPOSOME; NANOSPHERE; NANOTUBE; QUANTUM DOT; NANOPARTICLE;

ARTICLE; CELL FATE; CELL MIGRATION; CELL ORGANELLE; CONJUGATE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; HUMAN; PROCEDURES;

DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; ORGANELLES;

EID: 84953397607     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00697     Document Type: Article

References (48)

1. Torchilin, V. P. Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting Annu. Rev. Biomed. Eng. 2006, 8, 343-75 10.1146/annurev.bioeng.8.061505.095735
2. Breunig, M.; Bauer, S.; Goepferich, A. Polymers and Nanoparticles: Intelligent Tools for Intracellular Targeting? Eur. J. Pharm. Biopharm. 2008, 68 (1) 112-28 10.1016/j.ejpb.2007.06.010
3. Prokop, A.; Davidson, J. M. Nanovehicular Intracellular Delivery Systems J. Pharm. Sci. 2008, 97 (9) 3518-90 10.1002/jps.21270
4. D'Souza, G. G.; Weissig, V. Subcellular Targeting: A New Frontier for Drug-Loaded Pharmaceutical Nanocarriers and the Concept of the Magic Bullet Expert Opin. Drug Delivery 2009, 6 (11) 1135-48 10.1517/17425240903236101
5. Moghimi, S. M.; Hunter, A. C.; Andresen, T. L. Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective Annu. Rev. Pharmacol. Toxicol. 2012, 52, 481-503 10.1146/annurev-pharmtox-010611-134623
6. Stepensky, D., Pharmacokinetic and Pharmacodynamic Aspects of Focal and Targeted Delivery of Drugs. In Focal Controlled Drug Delivery, Domb, A. J.; Khan, W., Eds.; Springer, 2014.
7. Li, Y.; Wang, J.; Gao, Y.; Zhu, J.; Wientjes, M. G.; Au, J. L. S. Relationships between Liposome Properties, Cell Membrane Binding, Intracellular Processing, and Intracellular Bioavailability AAPS J. 2011, 13 (4) 585-97 10.1208/s12248-011-9298-1
8. Perry, J. L.; Reuter, K. G.; Kai, M. P.; Herlihy, K. P.; Jones, S. W.; Luft, J. C.; Napier, M.; Bear, J. E.; DeSimone, J. M. Pegylated Print Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics Nano Lett. 2012, 12 (10) 5304-10 10.1021/nl302638g
9. Rabanel, J. M.; Hildgen, P.; Banquy, X. Assessment of Peg on Polymeric Particles Surface, a Key Step in Drug Carrier Translation J. Controlled Release 2014, 185, 71-87 10.1016/j.jconrel.2014.04.017
10. Zhang, Q.; Gao, H.; He, Q. Taming Cell Penetrating Peptides: Never Too Old to Teach Old Dogs New Tricks Mol. Pharmaceutics 2015, 12 (9) 3105-18 10.1021/acs.molpharmaceut.5b00428
11. Patel, L. N.; Zaro, J. L.; Shen, W. C. Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives Pharm. Res. 2007, 24 (11) 1977-92 10.1007/s11095-007-9303-7
12. Zerangue, N.; Malan, M. J.; Fried, S. R.; Dazin, P. F.; Jan, Y. N.; Jan, L. Y.; Schwappach, B. Analysis of Endoplasmic Reticulum Trafficking Signals by Combinatorial Screening in Mammalian Cells Proc. Natl. Acad. Sci. U. S. A. 2001, 98 (5) 2431-6 10.1073/pnas.051630198
13. Yousif, L. F.; Stewart, K. M.; Horton, K. L.; Kelley, S. O. Mitochondria-Penetrating Peptides: Sequence Effects and Model Cargo Transport ChemBioChem 2009, 10 (12) 2081-8 10.1002/cbic.200900017
14. Chacinska, A.; Koehler, C. M.; Milenkovic, D.; Lithgow, T.; Pfanner, N. Importing Mitochondrial Proteins: Machineries and Mechanisms Cell 2009, 138 (4) 628-44 10.1016/j.cell.2009.08.005
15. Cocheme, H. M.; Kelso, G. F.; James, A. M.; Ross, M. F.; Trnka, J.; Mahendiran, T.; Asin-Cayuela, J.; Blaikie, F. H.; Manas, A. R.; Porteous, C. M.; Adlam, V. J.; Smith, R. A.; Murphy, M. P. Mitochondrial Targeting of Quinones: Therapeutic Implications Mitochondrion 2007, 7 (Suppl) S94-102 10.1016/j.mito.2007.02.007
16. Lu, P.; Bruno, B. J.; Rabenau, M.; Lim, C. S. Delivery of Drugs and Macromolecules to the Mitochondria for Cancer Therapy J. Controlled Release 2015, 10.1016/j.jconrel.2015.10.023
17. Kaplun, V.; Stepensky, D. Efficient Decoration of Nanoparticles Intended for Intracellular Drug Targeting with Targeting Residues, as Revealed by a New Indirect Analytical Approach Mol. Pharmaceutics 2014, 11 (8) 2906-14 10.1021/mp500253r
18. Sneh-Edri, H.; Likhtenshtein, D.; Stepensky, D. Intracellular Targeting of PLGA Nanoparticles Encapsulating Antigenic Peptide to the Endoplasmic Reticulum of Dendritic Cells and Its Effect on Antigen Cross-Presentation In Vitro Mol. Pharmaceutics 2011, 8 (4) 1266-75 10.1021/mp200198c
19. Tachibana, R.; Harashima, H.; Shono, M.; Azumano, M.; Niwa, M.; Futaki, S.; Kiwada, H. Intracellular Regulation of Macromolecules Using pH-Sensitive Liposomes and Nuclear Localization Signal: Qualitative and Quantitative Evaluation of Intracellular Trafficking Biochem. Biophys. Res. Commun. 1998, 251 (2) 538-44 10.1006/bbrc.1998.9460
20. Maity, A. R.; Stepensky, D. Delivery of Drugs to Intracellular Organelles Using Drug Delivery Systems: Analysis of Research Trends and Targeting Efficiencies Int. J. Pharm. 2015, 10.1016/j.ijpharm.2015.10.053
21. Battigelli, A.; Russier, J.; Venturelli, E.; Fabbro, C.; Petronilli, V.; Bernardi, P.; Da Ros, T.; Prato, M.; Bianco, A. Peptide-Based Carbon Nanotubes for Mitochondrial Targeting Nanoscale 2013, 5 (19) 9110-7 10.1039/c3nr02694a
22. Kocbek, P.; Kralj, S.; Kreft, M. E.; Kristl, J. Targeting Intracellular Compartments by Magnetic Polymeric Nanoparticles Eur. J. Pharm. Sci. 2013, 50 (1) 130-8 10.1016/j.ejps.2013.04.004
23. Delehanty, J. B.; Boeneman, K.; Bradburne, C. E.; Robertson, K.; Bongard, J. E.; Medintz, I. L. Peptides for Specific Intracellular Delivery and Targeting of Nanoparticles: Implications for Developing Nanoparticle-Mediated Drug Delivery Ther. Delivery 2010, 1 (3) 411-33 10.4155/tde.10.27
24. Ma, X.; Wang, X.; Zhou, M.; Fei, H. A Mitochondria-Targeting Gold-Peptide Nanoassembly for Enhanced Cancer-Cell Killing Adv. Healthcare Mater. 2013, 2 (12) 1638-43 10.1002/adhm.201300037
25. Han, M.; Vakili, M. R.; Soleymani Abyaneh, H.; Molavi, O.; Lai, R.; Lavasanifar, A. Mitochondrial Delivery of Doxorubicin via Triphenylphosphine Modification for Overcoming Drug Resistance in MDA-MB-435/Dox Cells Mol. Pharmaceutics 2014, 11 (8) 2640-9 10.1021/mp500038g
26. Liu, Y.; Tseng, Y. C.; Huang, L. Biodistribution Studies of Nanoparticles Using Fluorescence Imaging: A Qualitative or Quantitative Method? Pharm. Res. 2012, 29 (12) 3273-7 10.1007/s11095-012-0818-1
27. Horobin, R. W.; Stockert, J. C.; Rashid-Doubell, F. Uptake and Localisation of Small-Molecule Fluorescent Probes in Living Cells: A Critical Appraisal of QSAR Models and a Case Study Concerning Probes for DNA and RNA Histochem. Cell Biol. 2013, 139 (5) 623-37 10.1007/s00418-013-1090-0
28. Smith, R. A.; Hartley, R. C.; Cocheme, H. M.; Murphy, M. P. Mitochondrial Pharmacology Trends Pharmacol. Sci. 2012, 33 (6) 341-52 10.1016/j.tips.2012.03.010
29. Rin Jean, S.; Tulumello, D. V.; Wisnovsky, S. P.; Lei, E. K.; Pereira, M. P.; Kelley, S. O. Molecular Vehicles for Mitochondrial Chemical Biology and Drug Delivery ACS Chem. Biol. 2014, 9 (2) 323-33 10.1021/cb400821p
30. Stepensky, D. Quantitative Aspects of Intracellularly-Targeted Drug Delivery Pharm. Res. 2010, 27 (12) 2776-80 10.1007/s11095-010-0253-0
31. Paillard, A.; Hindre, F.; Vignes-Colombeix, C.; Benoit, J. P.; Garcion, E. The Importance of Endo-Lysosomal Escape with Lipid Nanocapsules for Drug Subcellular Bioavailability Biomaterials 2010, 31 (29) 7542-54 10.1016/j.biomaterials.2010.06.024
32. Decuzzi, P.; Godin, B.; Tanaka, T.; Lee, S. Y.; Chiappini, C.; Liu, X.; Ferrari, M. Size and Shape Effects in the Biodistribution of Intravascularly Injected Particles J. Controlled Release 2010, 141 (3) 320-7 10.1016/j.jconrel.2009.10.014
33. Ernsting, M. J.; Murakami, M.; Roy, A.; Li, S. D. Factors Controlling the Pharmacokinetics, Biodistribution and Intratumoral Penetration of Nanoparticles J. Controlled Release 2013, 172 (3) 782-94 10.1016/j.jconrel.2013.09.013
34. El-Sayed, A.; Futaki, S.; Harashima, H. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment AAPS J. 2009, 11 (1) 13-22 10.1208/s12248-008-9071-2
35. Zahid, M.; Robbins, P. D. Cell-Type Specific Penetrating Peptides: Therapeutic Promises and Challenges Molecules 2015, 20 (7) 13055-70 10.3390/molecules200713055
36. Ishida, T.; Kiwada, H. Accelerated Blood Clearance (ABC) Phenomenon Upon Repeated Injection of PEGylated Liposomes Int. J. Pharm. 2008, 354 (1-2) 56-62 10.1016/j.ijpharm.2007.11.005
37. Schellekens, H.; Hennink, W. E.; Brinks, V. The Immunogenicity of Polyethylene Glycol: Facts and Fiction Pharm. Res. 2013, 30 (7) 1729-34 10.1007/s11095-013-1067-7
38. Suzuki, T.; Ichihara, M.; Hyodo, K.; Yamamoto, E.; Ishida, T.; Kiwada, H.; Kikuchi, H.; Ishihara, H. Influence of Dose and Animal Species on Accelerated Blood Clearance of PEGylated Liposomal Doxorubicin Int. J. Pharm. 2014, 476 (1-2) 205-12 10.1016/j.ijpharm.2014.09.047
39. Torchilin, V. Tumor Delivery of Macromolecular Drugs Based on the Epr Effect Adv. Drug Delivery Rev. 2011, 63 (3) 131-5 10.1016/j.addr.2010.03.011
40. Maeda, H. Macromolecular Therapeutics in Cancer Treatment: The EPR Effect and Beyond J. Controlled Release 2012, 164 (2) 138-44 10.1016/j.jconrel.2012.04.038
41. Hamdy, S.; Haddadi, A.; Hung, R. W.; Lavasanifar, A. Targeting Dendritic Cells with Nano-Particulate PLGA Cancer Vaccine Formulations Adv. Drug Delivery Rev. 2011, 63 (10-11) 943-55 10.1016/j.addr.2011.05.021
42. Joshi, M. D.; Unger, W. J.; Storm, G.; van Kooyk, Y.; Mastrobattista, E. Targeting Tumor Antigens to Dendritic Cells Using Particulate Carriers J. Controlled Release 2012, 161 (1) 25-37 10.1016/j.jconrel.2012.05.010
43. Landsiedel, R.; Fabian, E.; Ma-Hock, L.; van Ravenzwaay, B.; Wohlleben, W.; Wiench, K.; Oesch, F. Toxico-/Biokinetics of Nanomaterials Arch. Toxicol. 2012, 86 (7) 1021-60 10.1007/s00204-012-0858-7
44. Elsaesser, A.; Howard, C. V. Toxicology of Nanoparticles Adv. Drug Delivery Rev. 2012, 64 (2) 129-37 10.1016/j.addr.2011.09.001
45. Doktorovova, S.; Souto, E. B.; Silva, A. M. Nanotoxicology Applied to Solid Lipid Nanoparticles and Nanostructured Lipid Carriers-a Systematic Review of In Vitro Data Eur. J. Pharm. Biopharm. 2014, 87 (1) 1-18 10.1016/j.ejpb.2014.02.005
46. Varkouhi, A. K.; Scholte, M.; Storm, G.; Haisma, H. J. Endosomal Escape Pathways for Delivery of Biologicals J. Controlled Release 2011, 151 (3) 220-8 10.1016/j.jconrel.2010.11.004
47. Love, S. A.; Maurer-Jones, M. A.; Thompson, J. W.; Lin, Y. S.; Haynes, C. L. Assessing Nanoparticle Toxicity Annu. Rev. Anal. Chem. 2012, 5, 181-205 10.1146/annurev-anchem-062011-143134
48. Dobrovolskaia, M. A.; McNeil, S. E. Understanding the Correlation between In Vitro and In Vivo Immunotoxicity Tests for Nanomedicines J. Controlled Release 2013, 172 (2) 456-66 10.1016/j.jconrel.2013.05.025